Mosaic Provides Additional Investor Education Material 
Captis Intelligence Partners With Milestone Systems to Launch Industry-First, VMS-Embedded Subject Identification Application BIONIK Laboratories Third Quarter Fiscal 2019 Financial Results Feature 256% Increase in Sales
TORONTO & BOSTON–(BUSINESS WIRE)–BIONIK Laboratories Corp. (OTCQB:BNKL) (“BIONIK” or the “Company”), a robotics company focused…
M Science Named “Best Alternative Data Provider” at 2019 HFM US Hedge Fund Technology Awards
NEW YORK–(BUSINESS WIRE)–M Science, the pioneer in data-driven research and analytics, is proud to have…
Media Alert: A10 Networks to Share 5G Security Insights and Strategy at MWC Barcelona 2019
A10 Networks Helps Mobile Operators to Future-Proof their Networks and Prepare for Mainstream Adoption of…
Telaria Offers The Trade Desk’s Unified ID Solution
NEW YORK & LOS ANGELES–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/videoelevated?src=hash” target=”_blank”gt;#videoelevatedlt;/agt;–Telaria (NYSE:TLRA), the complete software platform to manage…
MAXON Cinema 4D MoGraph Toolset Honored with Academy Certificate for Scientific and Technical Achievement
Academy of Motion Picture Arts and Sciences Recognizes Per-Anders Edwards for Initial Development of 3D…
Origami Capital Partners Issues Open Letter to the Board of Medley Capital Corporation
Origami seeks to acquire 100% interests of the Medley SBIC for $45 million in cash…
IQVIA Introduces RIM Smart, the Industry’s First Fully Integrated, End-to-End Regulatory Information Management System
More than regulatory information management (RIM), IQVIA RIM Smart delivers intelligent, interconnected global management across…
Stellex Capital Completes Strategic Investment in Cisco Equipment in Partnership with the Sibert Family
NEW YORK–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Automotive?src=hash” target=”_blank”gt;#Automotivelt;/agt;–Stellex Capital Management LP (“Stellex”), an investment firm with offices in…
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
– ADCETRIS in Combination with AVD (Adriamycin, Vinblastine and Dacarbazine) Demonstrated 29-Percent Reduction in the…
MicroStrategy Named a Technology Innovation Leader by Dresner Advisory Services for the Second Consecutive Year
MicroStrategy Wins for Analytics Leadership in Embedded BI, Location Intelligence, IoT Intelligence and Collective Insights®…